Clinical Trial Update: Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating gemcitabine hydrochloride or pemetrexed disodium with carboplatin, with or without celecoxib, in patients with advanced non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Celecoxib (Celecoxib)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2018-07-23